Article
Biological heterogeneity in diffuse large B-cell lymphoma
1 Nov 2023
Abstract excerpt
Diffuse large B-cell lymphoma (DLBCL) is heterogeneous both in clinical outcomes and the underlying disease biology. Over the last 2 decades, several different approaches for dissecting biological heterogeneity have emerged. Gene expression profiling (GEP) stratifies DLBCL into 3 broad groups (ABC, GCB, and DZsig/MHG), each with parallels to different normal mature B cell developmental states and prognostic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
